| Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
|---|
| C400184 |
1-palmitoyl-2-(5-oxovaleroyl)-sn-glycero-3-phosphorylcholine |
1-palmitoyl-2-(5-oxovaleroyl)-sn-glycero-3-phosphorylcholine results in increased expression of AGTR1 mRNA | increases expression | 16386258
|
| C023035 |
3,4,5,3',4'-pentachlorobiphenyl |
3,4,5,3',4'-pentachlorobiphenyl results in increased expression of AGTR1 mRNA | increases expression | 14962509
|
| D016604 |
Aflatoxin B1 |
Aflatoxin B1 affects the expression of AGTR1 protein | affects expression | 20106945
|
| C081643 |
candesartan |
candesartan binds to and results in decreased activity of AGTR1 protein | affects binding|decreases activity | 17763956 10525314
|
| C077793 |
candesartan cilexetil |
candesartan cilexetil binds to and results in decreased activity of AGTR1 protein | affects binding|decreases activity | 11086231
|
| D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of AGTR1 mRNA | decreases expression | 20106945
|
| D004958 |
Estradiol |
Estradiol inhibits the reaction [AGT protein results in increased expression of AGTR1 mRNA] | decreases reaction|increases expression | 16097371
|
| D004958 |
Estradiol |
Estradiol inhibits the reaction [AGT protein results in increased expression of AGTR1 protein] | decreases reaction|increases expression | 16097371
|
| D004958 |
Estradiol |
Estradiol results in decreased expression of AGTR1 mRNA | decreases expression | 20106945 15159206
|
| D004964 |
Estriol |
Estriol results in decreased expression of AGTR1 mRNA | decreases expression | 15159206
|
| C081309 |
irbesartan |
AGTR1 gene polymorphism affects the susceptibility to irbesartan | affects response to substance | 11910301
|
| C081309 |
irbesartan |
irbesartan binds to and results in decreased activity of AGTR1 protein | affects binding|decreases activity | 12022239
|
| D019808 |
Losartan |
Losartan binds to and results in decreased activity of AGTR1 protein | affects binding|decreases activity | 15807884 10821809
|
| D019808 |
Losartan |
Losartan binds to and results in decreased activity of AGTR1 protein | affects binding|decreases activity | 15809360
|
| D019808 |
Losartan |
Losartan binds to and affects the activity of AGTR1 protein | affects activity|affects binding | 14630723
|
| D019808 |
Losartan |
Losartan binds to and results in decreased activity of AGTR1 protein | affects binding|decreases activity | 15816410
|
| D019808 |
Losartan |
Losartan results in decreased activity of AGTR1 protein | decreases activity | 15681704
|
| C437965 |
olmesartan |
olmesartan binds to and results in decreased activity of AGTR1 protein | affects binding|decreases activity | 18434761
|
| C097933 |
olmesartan medoxomil |
olmesartan medoxomil binds to and results in decreased activity of AGTR1 protein | affects binding|decreases activity | 15467259
|
| C097933 |
olmesartan medoxomil |
olmesartan medoxomil results in decreased activity of AGTR1 protein | decreases activity | 16336959
|
| D010047 |
Ovalbumin |
Ovalbumin results in increased expression of AGTR1 protein | increases expression | 19080339
|
| C073402 |
PD 123319 |
PD 123319 results in decreased expression of AGTR1 mRNA | decreases expression | 11705791
|
| D010972 |
Platelet Activating Factor |
Platelet Activating Factor results in increased expression of AGTR1 mRNA | increases expression | 16386258
|
| D013974 |
Thyroxine |
Thyroxine results in increased expression of AGTR1 mRNA | increases expression | 18093424
|
| C084178 |
telmisartan |
telmisartan binds to and results in decreased activity of AGTR1 protein | affects binding|decreases activity | 9728324
|
| D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of AGTR1 mRNA | decreases expression | 20106945
|
| C081489 |
valsartan |
valsartan binds to and results in decreased activity of AGTR1 protein | affects binding|decreases activity | 15831366
|
| Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
|---|
| MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
2.79 | 15322242 14514962 11752688 |
| MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
2.08 | 11473722 |
| MESH:D018248 |
Adenoma, Liver Cell |
|
3,4,5,3',4'-pentachlorobiphenyl |
10.34 | 16628245 |
| MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
10.34 | 16835633 |
| MESH:D000419 |
Albuminuria |
|
Losartan |
5.78 | 12586211 |
| MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.89 | 11748828 |
| MESH:D050197 |
Atherosclerosis |
|
Losartan |
4.45 | 10821809 |
| MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
2.98 | 12125929 |
| MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.73 | 15340226 |
| MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.72 | 15746008 |
| MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
1.95 | 12948864 17261762 16675129 19861407 14630087 17289903 18497071 17018787 |
| MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.95 | 20435547 |
| MESH:D016535 |
Bronchial Hyperreactivity |
|
Ovalbumin |
5.31 | 12794006 |
| MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.40 | 16111702 |
| MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.74 | 16835633 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
Aflatoxin B1 |
3.00 | 12619106 21507988 12907637 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
3.00 | 16924424 |
| MESH:D006332 |
Cardiomegaly |
|
Losartan |
16.18 | 15969258 12586211 |
| MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
16.18 | 18670907 18850075 16120746 |
| MESH:D006332 |
Cardiomegaly |
|
Thyroxine |
16.18 | 18093424 |
| MESH:D006332 |
Cardiomegaly |
|
valsartan |
16.18 | 19597038 |
| MESH:D009202 |
Cardiomyopathies |
|
valsartan |
4.39 | 16247790 |
| MESH:D002318 |
Cardiovascular Diseases |
|
valsartan |
4.25 | 11230374 |
| MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
6.42 | 12371664 |
| MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
6.42 | 18566989 |
| MESH:D018281 |
Cholangiocarcinoma |
|
3,4,5,3',4'-pentachlorobiphenyl |
9.62 | 16628245 |
| MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
9.62 | 16835633 |
| MESH:D002779 |
Cholestasis |
|
Cyclosporine |
2.87 | 19486331 |
| MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.08 | 15668235 8697196 12621046 16354765 15340226 |
| MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.00 | 17141729 14669216 |
| MESH:D003324 |
Coronary Artery Disease |
|
valsartan |
3.87 | 17719468 |
| MESH:D003384 |
Coxsackievirus Infections |
|
valsartan |
5.78 | 20392896 |
| MESH:D019465 |
Craniofacial Abnormalities |
|
3,4,5,3',4'-pentachlorobiphenyl |
2.90 | 17686920 |
| MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
2.90 | 15322242 20055451 10048152 |
| MESH:D003921 |
Diabetes Mellitus, Experimental |
|
valsartan |
4.54 | 11508273 |
| MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.65 | 17107852 |
| MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
9.13 | 19279558 |
| MESH:D003928 |
Diabetic Nephropathies |
|
valsartan |
9.13 | 11427623 18630688 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
1.52 | 20420201 |
| MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.71 | 11462148 |
| MESH:D004374 |
Ductus Arteriosus, Patent |
marker/mechanism |
|
| 12904590 |
| MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
2.32 | 11000095 12711302 |
| MESH:D004489 |
Edema, Cardiac |
|
3,4,5,3',4'-pentachlorobiphenyl |
12.23 | 17686920 |
| MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
12.23 | 16714409 15322242 18230668 |
| MESH:D004714 |
Endometrial Hyperplasia |
|
Estriol |
6.01 | 16402032 |
| MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
2.94 | 19148513 11473722 18566989 |
| MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
2.96 | 9294722 10568697 |
| MESH:D004751 |
Enteritis |
|
candesartan |
6.29 | 17763956 |
| MESH:D004802 |
Eosinophilia |
|
Ovalbumin |
5.41 | 12689652 |
| MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
2.96 | 11564622 |
| MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
2.79 | 19224547 |
| MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.39 | 11858732 |
| MESH:D005355 |
Fibrosis |
|
Cyclosporine |
14.52 | 12168785 12639820 |
| MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
14.52 | 20067830 |
| MESH:D005355 |
Fibrosis |
|
valsartan |
14.52 | 16893502 |
| MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.16 | 8708960 |
| MESH:D015432 |
Glomerulonephritis, Membranoproliferative |
|
valsartan |
5.48 | 16928621 |
| MESH:D005923 |
Glomerulosclerosis, Focal Segmental |
|
candesartan |
5.83 | 16687628 |
| MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.54 | 10696789 |
| MESH:D006330 |
Heart Defects, Congenital |
|
3,4,5,3',4'-pentachlorobiphenyl |
6.89 | 20471113 17686920 |
| MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
6.89 | 10048152 11294989 |
| MESH:D006331 |
Heart Diseases |
|
olmesartan medoxomil |
5.51 | 15467259 |
| MESH:D006333 |
Heart Failure |
|
Losartan |
8.02 | 10979640 |
| MESH:D006333 |
Heart Failure |
|
valsartan |
8.02 | 19027736 |
| MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.36 | 15720958 |
| MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.27 | 11000095 |
| MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
2.83 | 16120746 12621046 15340226 |
| MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
4.98 | 15709030 |
| MESH:D019584 |
Hot Flashes |
|
Estradiol |
3.70 | 17088409 |
| MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.99 | 8697196 18606429 16354765 15340226 16959395 |
| MESH:D006973 |
Hypertension |
|
Cyclosporine |
24.64 | 10903974 |
| MESH:D006973 |
Hypertension |
|
irbesartan |
24.64 | 13678427 14700505 15453913 12359989 12022239 18464745 15188945 11910301 15614026 11593098 |
| MESH:D006973 |
Hypertension |
|
Losartan |
24.64 | 12512695 14597852 15969258 12586211 10090350 |
| MESH:D006973 |
Hypertension |
|
olmesartan medoxomil |
24.64 | 15467259 |
| MESH:D006973 |
Hypertension |
|
telmisartan |
24.64 | 16077267 |
| MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
24.64 | 18670907 18850075 |
| MESH:D006973 |
Hypertension |
|
valsartan |
24.64 | 18344623 18390891 12692753 11427623 20102058 12850387 10903974 16475468 |
| OMIM:145500 |
HYPERTENSION, ESSENTIAL |
marker/mechanism |
|
| |
| MESH:D006974 |
Hypertension, Malignant |
|
valsartan |
6.36 | 11560862 |
| MESH:D007249 |
Inflammation |
|
Losartan |
5.40 | 12586211 |
| MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
5.40 | 12200463 12878042 |
| MESH:D007333 |
Insulin Resistance |
|
Estradiol |
2.92 | 16627594 16393666 |
| MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.27 | 16580747 |
| MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.39 | 15604871 |
| MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
14.30 | 8314463 10903974 18776723 |
| MESH:D007674 |
Kidney Diseases |
|
Estradiol |
14.30 | 15618244 |
| MESH:D007674 |
Kidney Diseases |
|
olmesartan medoxomil |
14.30 | 15467259 |
| MESH:D007674 |
Kidney Diseases |
|
valsartan |
14.30 | 10903974 16893502 12164870 |
| MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
7.09 | 12371664 |
| MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
7.09 | 15610895 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
candesartan cilexetil |
6.74 | 14620537 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
6.74 | 14659978 14716833 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Losartan |
6.74 | 17900296 15573910 12445418 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
6.74 | 12878042 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
valsartan |
6.74 | 16872305 15504291 15619341 |
| MESH:D008113 |
Liver Neoplasms |
|
Aflatoxin B1 |
4.36 | 9163691 18177683 2125692 15890375 |
| MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
4.36 | 16984957 |
| MESH:D008114 |
Liver Neoplasms, Experimental |
|
Aflatoxin B1 |
5.67 | 8603461 |
| MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
5.67 | 12151625 |
| MESH:D008175 |
Lung Neoplasms |
|
Aflatoxin B1 |
2.28 | 14755239 |
| MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
2.28 | 19555203 11884234 |
| MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
2.52 | 11807958 17203775 16891317 11408345 |
| MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
4.43 | 19453300 |
| MESH:D008382 |
Marfan Syndrome |
|
Losartan |
6.00 | 19430350 |
| MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.73 | 16801185 |
| MESH:D008881 |
Migraine Disorders |
|
candesartan |
5.23 | 18759728 |
| MESH:D009203 |
Myocardial Infarction |
|
Losartan |
4.22 | 12692751 |
| MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
2.96 | 12213967 |
| MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
9.40 | 16810080 |
| MESH:D015428 |
Myocardial Reperfusion Injury |
|
olmesartan |
9.40 | 18434761 |
| MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
3.67 | 17289903 |
| MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.39 | 17954296 |
| MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.23 | 19348381 18481113 |
| MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
9.25 | 11399458 16427766 |
| MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
9.25 | 14600291 |
| MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
2.20 | 19401270 |
| MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.19 | 12520081 |
| MESH:D010911 |
Pituitary Neoplasms |
marker/mechanism |
|
| 16977796 |
| MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.49 | 18163543 |
| MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.16 | 12371664 |
| MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.13 | 11896295 11118676 11399792 11222880 |
| MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
3.82 | 20887781 |
| MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
3.10 | 16740699 |
| MESH:D011507 |
Proteinuria |
|
candesartan |
15.75 | 16687628 |
| MESH:D011507 |
Proteinuria |
|
telmisartan |
15.75 | 16077267 |
| MESH:D011507 |
Proteinuria |
|
valsartan |
15.75 | 12164870 17664856 18344623 |
| MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.21 | 16882103 |
| MESH:D011658 |
Pulmonary Fibrosis |
|
valsartan |
3.79 | 17241526 |
| MESH:D051437 |
Renal Insufficiency |
|
Losartan |
5.46 | 15728788 |
| OMIM:267430 |
RENAL TUBULAR DYSGENESIS |
marker/mechanism |
|
| |
| MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.77 | 18990726 |
| MESH:D012220 |
Rhinitis |
|
Ovalbumin |
5.34 | 18298128 12689652 |
| MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
2.01 | 16192470 |
| MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
12.19 | 12697716 |
| MESH:D013959 |
Thyroid Diseases |
|
Thyroxine |
12.19 | 19910387 |
| MESH:D013978 |
Tibial Fractures |
|
Estradiol |
4.63 | 19048282 |
| MESH:D014605 |
Uveitis |
|
Cyclosporine |
3.93 | 1336536 |
| MESH:D014652 |
Vascular Diseases |
|
olmesartan medoxomil |
6.69 | 15467259 |
| MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.54 | 12125929 |
| MESH:D020257 |
Ventricular Remodeling |
|
valsartan |
5.64 | 19027736 |
| MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.19 | 15886252 |
| MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.39 | 17120751 |